Elizabeth Robinson



​Co-founder and Vice Chairwoman of Indaco Venture Partners SGR. Previously she served as Investment Director Venture Capital at Quadrivio SGR from 2014 to mid-2018, when she left that role to found Indaco. She also served as Venture 

Consultant for Sofinnova Partners in Paris from 2005 to 2008. She has been an Angel investor for over 10 years. Elizabeth has broad experience in life sciences and the development and granting of licences for innovative pharmaceutical products. She was a co-founder of NicOx S.A.(1997) and President of NicOx Research Institute from 2006 to November 2022. She is a member of the Board of Directors of Brembo S.p.A., a listed company. Previously, she served on the Board of Directors of several companies operating in the life sciences sector in Italy including MolMed S.p.A. She was a member of the Fulbright Committee in Italy from 2007 to 2020. 

She is a Board member of the Penta Foundation, a no profit organisation aiming to develop treatments for paediatric infectious diseases. She is also committed to actively support the education of girls living in underdeveloped areas and the cultural development of Italy’s rural areas. 

In her career, Elizabeth has served as Director, Product Development, at Recordati Italy (1990-1996); Consultant, Technology Development, at Techint Engineering Company (1988-1990); Vice President, New Technology Ventures Europe, at Genzyme (1985-1988); Visiting Scientist at MIT (1984-1987); and Post Doctorate Research Associate at MIT (1982-1984). Elizabeth graduated Phi Beta Kappa from Wellesley College in 1977, received her M.S. in Chemical Engineering from Massachusetts Institute of Technology in 1979 and her Ph.D. in biotechnology from MIT in 1982. ​​